Bioavailability, Bioequivalence & Bioethics

The concept of BE has been accepted worldwide by the pharmaceutical industry and national regulatory authorities for over 20 years and is applied to new as well as generic products. As a result, thousands of high-quality generic drugs at reduced costs have become available in every corner of the globe. The assessment of BE is not a simple issue, however, and much of the research has been done in recent years to develop new and more effective approaches to the assessment of BE.

Since then, and after turn of the century, tremendous advancements have been made by the FDA and other regulatory authorities (national, international, and supranational), and by industry and academia in the area of assessment of bioequivalence. Currently approaches to determine BE of pharmaceutical products has been largely standardized. This has occurred due to discussion and consensus reached among various stakeholders at numerous national and international meetings, conferences, and workshops.

The pharmaceutical firms all over the world are burning the candle at both ends for attainment of market authorizations in various nations.

Bioethics can evaluate global justice by weighing human rights theory and future innovation at the macro level, and by addressing market forces and responsibilities at the micro level. Inherent structural features of pharmaceuticals, such as its reliance on research and development, cause the industry to employ pricing strategies that seem counter-intuitive to conventional wisdom, but that result in producing a just allocation as defined by market forces.

  • Scope of Guidelines
  • Pharmacokinetic and Pharmacodynamic Studies
  • In-Vitri and In Vivo Studoies
  • Bioethical challenges of new technology

Related Conference of Bioavailability, Bioequivalence & Bioethics

April 04-05, 2024

17th European Biosimilars Congress

Madrid, Spain
April 11-12, 2024

5th Annual Congress on Antibiotics and Bacterial Infections

Amsterdam, Netherlands
May 09-10, 2024

4th Global Summit on Pharmaceutical Research

Barcelona, Spain
May 16-17, 2024

18th World Drug Delivery Summit

Rome, Italy
May 30-31, 2024

9th Pharmaceutical Chemistry Conference

Paris, France
July 25-26, 2024

34th Annual European Pharma Congress

Frankfurt, Germany
September 11-12, 2024

9th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
September 25-26, 2024

4th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2024

3rd World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2024

3rd World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 28-29, 2024

39th World Congress on Pharmacology and Therapeutics

Paris, France
November 28-29, 2024

12th International Conference on Clinical Trials

Vancouver, Canada
December 05-06, 2024

17th World Drug Delivery Summit

Dubai, UAE

Bioavailability, Bioequivalence & Bioethics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in